automated-news
IonQ getting approval for SkyWater acquisition should improve its roadmap: Wedbush
automated-news
Intercontinental Exchange to acquire MarketAxess in $6B deal
Braveheart Bio Inc., a clinical-stage biopharmaceutical company backed by a16z, is seeking to raise as much as $318.8 million in an initial public offering, adding to a growing pipeline of listings in the sector.
Dislocations have created lucrative opportunities for companies able to source, transport and process energy across markets.
To see a country’s financial follies, look to its celebrity advisers
Philip R. Lane: Outlook for the euro area economy
Read the article here The post The CBDC tracker cited in Coindesk on the number of countries actively testing or developing CBDCs appeared first on Atlantic Council.
Read the publication The post Piasecki’s piece on African debt republished by Public Debt Management Network appeared first on Atlantic Council.
It seemed like a good idea at the time.
US stocks rose as strong growth at Microsoft Corp. reassured investors that expensive bets on AI are starting to pay off, outweighing resurgent worries about inflation that are pummeling long-dated bonds.